These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 16139690)

  • 1. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous cardiotonic steroids.
    Schoner W
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous cardiac glycosides, a new class of steroid hormones.
    Schoner W
    Eur J Biochem; 2002 May; 269(10):2440-8. PubMed ID: 12027881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
    Schoner W; Scheiner-Bobis G
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New steroid hormone family: endogenous cardiac glycosides and their role in physiologic and pathologic conditions].
    Somogyi J; Szalay J; Pándics T; Rosta K; Csermely P; Vér A
    Orv Hetil; 2004 Feb; 145(6):259-66. PubMed ID: 15038319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
    Hauck C; Frishman WH
    Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of cardiac steroids on intracellular membrane traffic in neuronal NT2 cells.
    Rosen H; Glukmann V; Feldmann T; Fridman E; Lichtstein D
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):78-86. PubMed ID: 17535740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
    Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
    Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
    Cherniavsky Lev M; Karlish SJ; Garty H
    Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
    Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
    Oselkin M; Tian D; Bergold PJ
    Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
    Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
    Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endogenous cardiotonic steroids in sodium homeostasis.
    Schoner W; Scheiner-Bobis G
    Nephrol Dial Transplant; 2008 Sep; 23(9):2723-9. PubMed ID: 18556748
    [No Abstract]   [Full Text] [Related]  

  • 17. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.
    Gentile DA; Henry J; Katz AJ; Skoner DP
    Ann Allergy Asthma Immunol; 1997 May; 78(5):466-72. PubMed ID: 9164359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabain interaction with cardiac Na/K-ATPase reveals that the enzyme can act as a pump and as a signal transducer.
    Xie Z
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):383-90. PubMed ID: 11357899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte sodium pump stimulation by ouabain and an endogenous ouabain-like factor.
    Balzan S; D'Urso G; Nicolini G; Forini F; Pellegrino M; Montali U
    Cell Biochem Funct; 2007; 25(3):297-303. PubMed ID: 17191274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.